|
|
|
40
|
A3611
|
ARCALION 200MG TAB (SER/STO) SULBUTIAMINE
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
23.73
|
1.19
|
TABLET
|
0
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
A3611
|
ARCALION 200MG TAB (SER) SULBUTIAMINE (C)
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
24.46
|
1.2232
|
TAB
|
0
|
BOX
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
A3611
|
ARCALION 200MG TAB (SER) SULBUTIAMINE
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
24.46
|
1.22
|
TAB
|
0
|
BLIS
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2026-04-01
|
|
|
ORAL
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
A3612
|
ARCALION 200MG TAB (SER/COL) SULBUTIAMINE
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
23.73
|
1.19
|
TABLET
|
0
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
A3612
|
ARCALION 200MG TAB (SER) SULBUTIAMI (C)
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
24.46
|
1.2232
|
TAB
|
0
|
BOX
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
A3612
|
ARCALION 200MG TAB (SER) SULBUTIAMI
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
24.46
|
1.22
|
TAB
|
0
|
BLIS
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
AVENTA BARBADOS
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2026-04-01
|
|
|
ORAL
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
A3613
|
SULBUTIAMINE 200MG TAB (KWA/ATB)
|
SULBUTIAMINE
|
SULBUTIAMINE
|
20'S
|
C
|
12.23
|
0.61
|
TABLET
|
0
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|